Tag: Europe
-
Nerve Stimulation Approved for Children’s Epilepsy
The U.S. Food and Drug Administration approved use of vagus nerve stimulation to treat epilepsy in children who do not respond to drug therapy as young as 4 years old.
-
Start-Up to Offer Neuro Disorder Speech Analytics App
A start-up enterprise in Germany is commercializing a software app to detect early signs of cognitive decline, found in dementia and other neurodegenerative disorders.
-
Immune Disease Start-Up Raises $28M in Early Funds
A new company founded to develop treatments for diseases caused by problems with the immune system is raising $28.4 million in its first round of financing.
-
Computer-Designed Antibodies Target Alzheimer’s Proteins
Researchers in Europe designed antibodies, like those in the immune system, to attack protein deposits in the brain associated with Alzheimer’s disease.
-
Cancer Drug Produced in Small Continuous-Flow Batches
A team from drug maker Eli Lilly & Company devised techniques for producing an experimental cancer drug in small quantities but with safe, economical methods used in continuous flow manufacturing.
-
$300M Fund to Back European Life Science Companies
A new investment fund plans to invest $300 million in European life science and biotechnology companies in the later stages of their product development.
-
Brain-Computer Device Tested with Consciousness Patients
Tests of a device designed for people with consciousness disorders to provide basic feedback to questions show the system can elicit and capture responses from these individuals.
-
Wearable Heartbeat Simulator Helps Reduce Stress
A device that sends rhythmic vibrations resembling heart beats into the wrist helps reduce stress among individuals facing the prospect of making a public speech.
-
Sound Waves, Nanotech Delivery Boost Cancer Drug
Focused sound waves aimed at nanoscale bubbles filled with a cancer drug, were shown in lab mice to improve delivery of the drug to a particularly hard-to-treat cancer.
-
Patent Awarded for COPD Dry Powder Inhaler Formula
A formulation for dry powder inhalers to treat respiratory diseases that its developers say delivers medication to the lungs more efficiently received a U.S. patent.